- Home
- NOG vs TNGX Comparison
NOG vs TNGX Comparison
Compare NOG & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NOG | TNGX |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.9B |
| IPO Year | 2000 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NOG | TNGX |
|---|---|---|
| Price | $21.48 | $28.68 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $31.14 | $21.78 |
| AVG Volume (30 Days) | 2.6M | ★ 3.7M |
| Earning Date | 04-28-2026 | 05-08-2026 |
| Dividend Yield | ★ 6.44% | N/A |
| EPS Growth | N/A | ★ 26.89 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,475,723,000.00 | $62,384,000.00 |
| Revenue This Year | $14.07 | N/A |
| Revenue Next Year | $4.24 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 11.23 | ★ 48.29 |
| 52 Week Low | $20.18 | $4.40 |
| 52 Week High | $32.62 | $32.79 |
Technical Indicators
Market Signals| Indicator | NOG | TNGX |
|---|---|---|
| Relative Strength Index (RSI) | 39.06 | 62.16 |
| Support Level | $21.41 | $19.85 |
| Resistance Level | $22.86 | N/A |
| Average True Range (ATR) | 0.72 | 2.06 |
| MACD | -0.01 | 1.04 |
| Stochastic Oscillator | 22.52 | 70.42 |
Price Performance
Historical ComparisonAbout NOG Northern Oil and Gas Inc.
Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.